
Atossa Therapeutics Inc (ATOS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -122.634 | -173.724 | -230.175 | -131.553 | -77.905 | -22.386 | -20.363 | -27.385 |
Return on Equity (%) | -186.255 | -213.053 | -290.701 | -157.006 | -110.761 | -24.931 | -21.054 | -28.801 |
Return on Invested Capital (%) | -215.314 | -146.621 | -146.704 | -157.201 | -77.035 | -24.918 | -22.085 | -31.438 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.649 | 0.216 | 1.489 | 1.433 | 0.558 | 1.086 | 0.927 | 0.726 |
Earnings Per Share | -1.682 | -0.336 | -3.914 | -1.888 | -0.47 | -0.163 | -0.213 | -0.24 |
Cash Per Share | 0.8 | 0.227 | 1.775 | 1.378 | 0.832 | 1.077 | 0.876 | 0.706 |
Working Capital Per Share | 0.583 | 0.21 | 1.477 | 1.423 | 0.57 | 1.091 | 0.889 | 0.694 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.682 | -0.255 | -1.951 | -1.888 | -0.375 | -0.163 | -0.213 | -0.24 |
EBITDA Per Share | -1.682 | -0.255 | -1.951 | -1.888 | -0.375 | -0.163 | -0.213 | -0.24 |
Free Cash Flow Per Share | -1.759 | -0.34 | -3.902 | -1.893 | -0.47 | -0.163 | -0.213 | -0.24 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,79M | 31,82M | 5,85M | 9,13M | 47,55M | 126,62M | 126,62M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 126,62M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 94,41M |
Ratio cours/bénéfice | -3,05 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,04 |
Ratio prix/valeur comptable | 1,01 |
Rendement de dividende | - |
Actions en circulation | 125,8M |
Volume moyen (1 semaine) | 440,92k |
Volume moyen (1 mois) | 532,53k |
Variation sur 52 semaines | -36,69% |
Plus haut sur 52 semaines | 2,31 |
Plus bas sur 52 semaines | 0,7064 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales